In colon cancer, GSCs are characterized by an increased ability of self-renewal, therapeutic resistance, and metastasis, and have been identified through surface markers such as CD44+, CD166+, ALDH+, CD44v6+ [8]. This evidence concerns the gene ALCAM and malignant colon neoplasm.